Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

5-HTTLPR genotype and gender, but not chronic fluoxetine administration, are associated with cortical TREK1 protein expression in rhesus macaques.

Bogdan R, Fitzgibbon H, Woolverton WL, Bethea CL, Iyo AH, Stockmeier CA, Kyle PB, Austin MC.

Neurosci Lett. 2011 Oct 3;503(2):83-6. doi: 10.1016/j.neulet.2011.08.005. Epub 2011 Aug 17.

2.

Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder.

Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Jiménez M, Galleguillos F, Bustamante ML.

Psychiatr Genet. 2010 Feb;20(1):25-30. doi: 10.1097/YPG.0b013e328335125d.

PMID:
20010449
4.

Effects of early experience and genotype on serotonin transporter regulation in infant rhesus macaques.

Kinnally EL, Lyons LA, Abel K, Mendoza S, Capitanio JP.

Genes Brain Behav. 2008 Jun;7(4):481-6. Epub 2007 Dec 6.

5.

Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use.

Sawyer EK, Mun J, Nye JA, Kimmel HL, Voll RJ, Stehouwer JS, Rice KC, Goodman MM, Howell LL.

Neuropsychopharmacology. 2012 Jul;37(8):1816-24. doi: 10.1038/npp.2012.29. Epub 2012 Mar 21.

6.

Bone growth in juvenile rhesus monkeys is influenced by 5HTTLPR polymorphisms and interactions between 5HTTLPR polymorphisms and fluoxetine.

Golub MS, Bulleri AM, Hogrefe CE, Sherwood RJ.

Bone. 2015 Oct;79:162-9. doi: 10.1016/j.bone.2015.05.042. Epub 2015 Jun 9.

7.

The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.

Smits KM, Smits LJ, Peeters FP, Schouten JS, Janssen RG, Smeets HJ, van Os J, Prins MH.

Psychiatr Genet. 2008 Aug;18(4):184-90. doi: 10.1097/YPG.0b013e3283050aca.

PMID:
18628680
8.

Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells.

Iceta R, Mesonero JE, Alcalde AI.

Life Sci. 2007 Mar 27;80(16):1517-24. Epub 2007 Jan 20.

PMID:
17289086
9.

Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells.

Singh YS, Altieri SC, Gilman TL, Michael HM, Tomlinson ID, Rosenthal SJ, Swain GM, Murphey-Corb MA, Ferrell RE, Andrews AM.

Transl Psychiatry. 2012 Feb 7;2:e77. doi: 10.1038/tp.2012.2.

10.

Serotonin transporter genotype and function in relation to antidepressant response in Koreans.

Myung W, Lim SW, Kim S, Kim H, Chung JW, Seo MY, Kim JW, Carroll BJ, Kim DK.

Psychopharmacology (Berl). 2013 Jan;225(2):283-90. doi: 10.1007/s00213-012-2813-y. Epub 2012 Aug 12.

PMID:
22885912
11.

The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.

Outhred T, Das P, Dobson-Stone C, Felmingham KL, Bryant RA, Nathan PJ, Malhi GS, Kemp AH.

Aust N Z J Psychiatry. 2014 Dec;48(12):1115-25. doi: 10.1177/0004867414533837. Epub 2014 May 8.

PMID:
24810870
12.

Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).

Eichhammer P, Langguth B, Wiegand R, Kharraz A, Frick U, Hajak G.

Psychopharmacology (Berl). 2003 Mar;166(3):294-7. Epub 2003 Feb 1.

PMID:
12563545
13.

Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment.

Bouet V, Klomp A, Freret T, Wylezinska-Arridge M, Lopez-Tremoleda J, Dauphin F, Boulouard M, Booij J, Gsell W, Reneman L.

Psychopharmacology (Berl). 2012 May;221(2):329-39. doi: 10.1007/s00213-011-2580-1. Epub 2011 Dec 24.

PMID:
22205158
14.

Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder.

Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Vielma W, Montes C, Pumarino L, Roa N.

Actas Esp Psiquiatr. 2007 Nov-Dec;35(6):387-92.

PMID:
17597424
15.

Prenatal fluoxetine exposure induces life-long serotonin 5-HT₃ receptor-dependent cortical abnormalities and anxiety-like behaviour.

Smit-Rigter LA, Noorlander CW, von Oerthel L, Chameau P, Smidt MP, van Hooft JA.

Neuropharmacology. 2012 Feb;62(2):865-70. doi: 10.1016/j.neuropharm.2011.09.015. Epub 2011 Sep 24.

PMID:
21964434
16.

Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype.

Hinkelmann K, Dragoi L, Gompf J, Muhtz C, Demiralay C, Yassouridis A, Wiedemann K, Kellner M.

Psychiatry Res. 2010 May 30;177(3):354-7. doi: 10.1016/j.psychres.2010.03.008. Epub 2010 Apr 8.

PMID:
20381161
17.

Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior.

Shrestha SS, Nelson EE, Liow JS, Gladding R, Lyoo CH, Noble PL, Morse C, Henter ID, Kruger J, Zhang B, Suomi SJ, Svenningsson P, Pike VW, Winslow JT, Leibenluft E, Pine DS, Innis RB.

Am J Psychiatry. 2014 Mar;171(3):323-31. doi: 10.1176/appi.ajp.2013.13020183.

18.

Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.

Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ, Kim DK.

JAMA. 2006 Oct 4;296(13):1609-18.

PMID:
17018806
19.

Optical probing of a dynamic membrane interaction that regulates the TREK1 channel.

Sandoz G, Bell SC, Isacoff EY.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2605-10. doi: 10.1073/pnas.1015788108. Epub 2011 Jan 24.

20.

Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.

Durkin S, Prendergast A, Harkin A.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1894-901. doi: 10.1016/j.pnpbp.2008.09.008. Epub 2008 Sep 13.

PMID:
18824064

Supplemental Content

Support Center